Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer SAN FRANCISCO and SUZHOU, China, Feb. 13, 2026 /PRNewswire/ — Innovent Biologics, Inc.… CISION PRNewswireFebruary 13, 2026
Press Release Cboe Launches Nearly 24-Hour Trading in Russell 2000 Index Options Cash-settled Russell 2000® Index (RUT) options now available during Cboe’s Global Trading… CISION PRNewswireFebruary 13, 2026
Press Release Elliott Management Statement on Toyota Industries Corporation Elliott does not intend to tender its shares into the Extended TOB… CISION PRNewswireFebruary 13, 2026
Titomic Enters Space Act Agreement with NASA HUNTSVILLE, Ala., Feb. 13, 2026 /PRNewswire/ — Titomic Limited (ASX: TTT), a… CISION PRNewswireFebruary 13, 2026
CGTN AMERICA & CCTV UN: CMG Presents "Prelude to the Spring Festival Gala" in New York City, Celebrating the Year of the Horse WASHINGTON, Feb. 13, 2026 /PRNewswire/ — CGTN America & CCTV UN releases… CISION PRNewswireFebruary 13, 2026
Press Release Opening of the Tuwaiq Sculpture 2026 Exhibition Marks Seventh Edition RIYADH, Saudi Arabia, Feb. 13, 2026 /PRNewswire/ — The Royal Commission for… CISION PRNewswireFebruary 13, 2026
Press Release SAUDI ARABIA ANNOUNCES 2026 FUTURE AVIATION FORUM TO CONVENE GLOBAL AVIATION LEADERS, EXTENDS RECORD-BREAKING AVIATION GROWTH The 2026 Future Aviation Forum will return to Riyadh from 20–22 April… CISION PRNewswireFebruary 13, 2026
Press Release SleepAI.com Introduces an AI-Powered Sleep and Emotional Wellness Platform for Modern Life LOS ANGELES, Feb. 13, 2026 /PRNewswire/ — SleepAI.com, a personalized AI sleep companion,… CISION PRNewswireFebruary 13, 2026
